Effect of blonanserin on cognitive impairment in schizophrenic patient-non-blinded, randomized, comparative study with olanzapine
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 03 Apr 2013
At a glance
- Drugs Blonanserin (Primary) ; Olanzapine
- Indications Schizophrenia
- Focus Therapeutic Use
- 03 Apr 2013 Planned end date changed from 1 May 2015 to 31 Dec 2015 as reported by University Hospital Medical Information Network - Japan record.
- 03 Apr 2013 Planned initiation date changed from 1 Aug 2012 to 1 Jun 2013 as reported by University Hospital Medical Information Network - Japan record.
- 07 Aug 2012 New trial record